A downtrend has been apparent in Galecto, Inc. (GLTO) lately. While the stock has lost 14.9% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...

Galecto Inc (NASDAQ:GLTO) shares are trading lower by 27% to $8.50 during Monday’s session. The company issued 62,594 shares of common stock and 160,562 of preferred convertible shares to Bridge ...

The average one-year price target for Galecto (NasdaqCM:GLTO) has been revised to $36.72 / share. This is an increase of 12.50% from the prior estimate of $32.64 dated December 3, 2025. The price ...

The average one-year price target for Galecto (NasdaqCM:GLTO) has been revised to $32.64 / share. This is an increase of 433.33% from the prior estimate of $6.12 dated August 30, 2025. The price ...

Shares of biotechnology company Galecto, Inc. (GLTO) soared 632% in the pre-market session on Tuesday. The stock is on track to hit over two-year highs. Galecto is focused on developing treatments for ...

In a report released today, Boobalan Pachaiyappan from H.C. Wainwright reiterated a Buy rating on Galecto (GLTO – Research Report), with a price target of $12.00. The company’s shares closed yesterday ...

September 29, 2022 – TheNewswire - Galecto (GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, has announced positive results from ...

Denmark-based biotechnology company Galecto (GLTO) has been making some progress on developing treatments for diseases such as fibrosis and cancer. The stock has gained 18.7% over the past month. But ...

The price trend for Galecto, Inc. (GLTO) has been bearish lately and the stock has lost 5.8% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session ...